Area of Interest:

Pharmacology and Toxicology

100%

Antimicrobial

62%

Nutrition

90%

Drug Delivery System

75%

Drug Analysis

55%

Research Publications in Numbers

Books
0

Chapters
0

Articles
0

Abstracts
0

Selected Publications

Jiang, Y., C.Y. Zhao, L.C. Cheng, B. Xu and H.Y. Lv, 2017. ARLTS1 polymorphism is associated with an increased risk of familial cancer: Evidence from a meta-analysis. Hereditary Cancer Clin. Pract., Vol. 15. 10.1186/s13053-017-0068-7.
CrossRef | Direct Link |
Hui, M.A., H.Y. Lv, X.J. Yu, Z.C. Hu, L.J. Sun, L.C. Cheng and C. Zhang, 2017. Effect of CYP2C19 gene polymorphism on the antiplatelet therapy of clopidogrel. China J. Clin. Pharmacol., 33: 1909-1911.
Geng, C.，Wudi，H.Y. Lu，Y.Z. Li, W.W. Shi, Y. Liu and J. Yin, 2017. Plasm a protein binding characteristics of neopanaxadiol in rats by UPLC-MS/MS. China Pharm. J., 52: 404-408.
Cheng, L.C., Y. Jiang, Y. Xie, L.L. Qiu, Q. Yang and H.Y. Lu, 2017. Novel amphiphilic folic acid-cholesterol-chitosan micelles for paclitaxel delivery. Oncotarget, 8: 3315-3326.
Direct Link |
Cheng, L.C., Q. Fan, M.A. Hui, H.Y. Lv, C.Y. Zhao and M.K. Shao, 2013. Preparation and in vitro targeted delivery of chitosan nanoparticles loaded with ligustrazine. Pharm. Care Res., 13: 452-455.
Zhang, N., C. Zhang, H.Y. Lv, Q. Fan and S. Deng, 2011. Systematic evaluation of the application of sirolimus in patients after liver transplantation. China Pharm., 22: 1705-1707.
Direct Link |
Hui-Yi, L., Q. Fan, , N. Zhang, C. Zhang and H. Ma, 2011. Association of donor CYP3A5 and MDR1 polymorphisms with the individual dosage regimen of tacrolimus in chinese liver transplantation recipients. Chinese Pharm. J., 17: 1366-1369.
Direct Link |
Lu, H.Y., Q. Fan, H. Ma, N. Zhang and C. Zhang, 2010. Analysis of CYP3A5 genetic polymorphism in kidney-transplanted patients to guide individual dosage regimen of tacrolimus administered after operation. Chinese J. Hospital Pharm., 30: 280-283.
Direct Link |